Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not?

Research output: Contribution to journal › Review › Research › peer-review

Standard

Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss : What Is Real and What Is Not? / Wang, Nathalie F; Kolte, Astrid M; Larsen, Elisabeth C; Nielsen, Henriette S; Christiansen, Ole B.

In: Clinical Obstetrics and Gynecology, Vol. 59, No. 3, 2016, p. 509-23.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Wang, NF, Kolte, AM, Larsen, EC, Nielsen, HS & Christiansen, OB 2016, 'Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not?', Clinical Obstetrics and Gynecology, vol. 59, no. 3, pp. 509-23. https://doi.org/10.1097/GRF.0000000000000215

APA

Wang, N. F., Kolte, A. M., Larsen, E. C., Nielsen, H. S., & Christiansen, O. B. (2016). Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not? Clinical Obstetrics and Gynecology, 59(3), 509-23. https://doi.org/10.1097/GRF.0000000000000215

Vancouver

Wang NF, Kolte AM, Larsen EC, Nielsen HS, Christiansen OB. Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not? Clinical Obstetrics and Gynecology. 2016;59(3):509-23. https://doi.org/10.1097/GRF.0000000000000215

Author

Wang, Nathalie F ; Kolte, Astrid M ; Larsen, Elisabeth C ; Nielsen, Henriette S ; Christiansen, Ole B. / Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss : What Is Real and What Is Not?. In: Clinical Obstetrics and Gynecology. 2016 ; Vol. 59, No. 3. pp. 509-23.

Bibtex

@article{458f1c0841a042dfa2303e5d2f6042b2,
title = "Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not?",
abstract = "Recurrent pregnancy loss, depending on the definition, affects 1% to 3% of women aiming to have a child. Little is known about the direct causes of recurrent pregnancy loss, and the condition is considered to have a multifactorial and complex pathogenesis. The aim of this review was to summarize the evaluation and the management of the condition with specific emphasis on immunologic biomarkers identified as risk factors as well as current immunologic treatment options. The review also highlights and discusses areas in need of further research.",
keywords = "Journal Article",
author = "Wang, {Nathalie F} and Kolte, {Astrid M} and Larsen, {Elisabeth C} and Nielsen, {Henriette S} and Christiansen, {Ole B}",
year = "2016",
doi = "10.1097/GRF.0000000000000215",
language = "English",
volume = "59",
pages = "509--23",
journal = "Clinical Obstetrics and Gynecology",
issn = "0009-9201",
publisher = "Lippincott Williams & Wilkins",
number = "3",

}

RIS

TY - JOUR

T1 - Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss

T2 - What Is Real and What Is Not?

AU - Wang, Nathalie F

AU - Kolte, Astrid M

AU - Larsen, Elisabeth C

AU - Nielsen, Henriette S

AU - Christiansen, Ole B

PY - 2016

Y1 - 2016

N2 - Recurrent pregnancy loss, depending on the definition, affects 1% to 3% of women aiming to have a child. Little is known about the direct causes of recurrent pregnancy loss, and the condition is considered to have a multifactorial and complex pathogenesis. The aim of this review was to summarize the evaluation and the management of the condition with specific emphasis on immunologic biomarkers identified as risk factors as well as current immunologic treatment options. The review also highlights and discusses areas in need of further research.

AB - Recurrent pregnancy loss, depending on the definition, affects 1% to 3% of women aiming to have a child. Little is known about the direct causes of recurrent pregnancy loss, and the condition is considered to have a multifactorial and complex pathogenesis. The aim of this review was to summarize the evaluation and the management of the condition with specific emphasis on immunologic biomarkers identified as risk factors as well as current immunologic treatment options. The review also highlights and discusses areas in need of further research.

KW - Journal Article

U2 - 10.1097/GRF.0000000000000215

DO - 10.1097/GRF.0000000000000215

M3 - Review

C2 - 27380207

VL - 59

SP - 509

EP - 523

JO - Clinical Obstetrics and Gynecology

JF - Clinical Obstetrics and Gynecology

SN - 0009-9201

IS - 3

ER -

ID: 181057274